SPINAL AND BULBAR MUSCULAR ATROPHY
Clinical trials for SPINAL AND BULBAR MUSCULAR ATROPHY explained in plain language.
Never miss a new study
Get alerted when new SPINAL AND BULBAR MUSCULAR ATROPHY trials appear
Sign up with your email to follow new studies for SPINAL AND BULBAR MUSCULAR ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major study tracks Real-World impact of rare muscle disease treatment
Disease control Recruiting nowThis study aims to monitor the long-term safety and effectiveness of an approved injection treatment for spinal and bulbar muscular atrophy (SBMA) in real-world medical settings. It will observe about 300 patients in Japan who are already receiving the treatment, tracking their h…
Matched conditions: SPINAL AND BULBAR MUSCULAR ATROPHY
Sponsor: Takeda • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists launch hunt for clues in rare Muscle-Wasting disease
Knowledge-focused Recruiting nowThis study aims to understand how spinal and bulbar muscular atrophy (SBMA or Kennedy's disease) progresses over time. Researchers will follow 70 men with and without the condition for two years, using tests like MRIs, blood work, and strength assessments. The goal is to find rel…
Matched conditions: SPINAL AND BULBAR MUSCULAR ATROPHY
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC